| Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, ... The Lancet Neurology 17 (10), 895-904, 2018 | 351 | 2018 |
| Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis … BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, ... The Lancet Neurology 18 (1), 46-55, 2019 | 321 | 2019 |
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia LH Meeter, EG Dopper, LC Jiskoot, R Sanchez‐Valle, C Graff, L Benussi, ... Annals of clinical and translational neurology 3 (8), 623-636, 2016 | 268 | 2016 |
| Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta … BCV Campbell, WH Van Zwam, M Goyal, BK Menon, DWJ Dippel, ... The Lancet Neurology 17 (1), 47-53, 2018 | 239 | 2018 |
| Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study FH Duits, P Martinez‐Lage, C Paquet, S Engelborghs, A Lleo, L Hausner, ... Alzheimer's & Dementia 12 (2), 154-163, 2016 | 236 | 2016 |
| Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease M Balasa, E Gelpi, A Antonell, MJ Rey, R Sanchez-Valle, JL Molinuevo, ... Neurology 76 (20), 1720-1725, 2011 | 160 | 2011 |
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study EL van der Ende, LH Meeter, JM Poos, JL Panman, LC Jiskoot, ... The Lancet Neurology 18 (12), 1103-1111, 2019 | 157 | 2019 |
| Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion M Ribo, CA Molina, E Cobo, N Cerdà, A Tomasello, H Quesada, ... Stroke 47 (4), 999-1004, 2016 | 147 | 2016 |
| Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease A Antonell, A Mansilla, L Rami, A Lladó, A Iranzo, J Olives, M Balasa, ... Journal of Alzheimer's Disease 42 (3), 901-908, 2014 | 128 | 2014 |
| A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease A Antonell, A Lladó, J Altirriba, T Botta-Orfila, M Balasa, M Fernández, ... Neurobiology of aging 34 (7), 1772-1778, 2013 | 117 | 2013 |
| Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial A Dávalos, E Cobo, CA Molina, A Chamorro, MA de Miquel, L San Román, ... The Lancet Neurology 16 (5), 369-376, 2017 | 103 | 2017 |
| White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β … JL Molinuevo, P Ripolles, M Simó, A Lladó, J Olives, M Balasa, A Antonell, ... Neurobiology of aging 35 (12), 2671-2680, 2014 | 91 | 2014 |
| Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease L Rami, R Sala-Llonch, C Solé-Padullés, J Fortea, J Olives, A Lladó, ... Journal of Alzheimer's disease 31 (3), 517-526, 2012 | 82 | 2012 |
| Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain D Alcolea, P Martínez-Lage, A Izagirre, M Clerigué, M Carmona-Iragui, ... Journal of Alzheimer's Disease 39 (4), 719-726, 2014 | 75 | 2014 |
| Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease R Sánchez-Valle, A Heslegrave, MS Foiani, B Bosch, A Antonell, ... Alzheimer's Research & Therapy 10, 1-6, 2018 | 72 | 2018 |
| CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome M Guasp, G Muñoz-Sánchez, E Martínez-Hernández, D Santana, ... Frontiers in immunology 13, 866153, 2022 | 70 | 2022 |
| The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study JL Molinuevo, JD Gispert, B Dubois, MT Heneka, A Lleo, S Engelborghs, ... Journal of Alzheimer's Disease 36 (1), 67-77, 2013 | 68 | 2013 |
| Different profiles of Alzheimer’s disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints A Antonell, J Fortea, L Rami, B Bosch, M Balasa, R Sánchez-Valle, ... Journal of neural transmission 118, 259-262, 2011 | 65 | 2011 |
| Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal‐dominant Alzheimer's disease M Carmona‐Iragui, M Balasa, B Benejam, D Alcolea, S Fernández, ... Alzheimer's & Dementia 13 (11), 1251-1260, 2017 | 63 | 2017 |
| Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias A Antonell, A Tort-Merino, J Ríos, M Balasa, S Borrego-Écija, JM Auge, ... Alzheimer's & Dementia, 2019 | 58 | 2019 |
